SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Announcement under Regulation 30 (LODR)-Conversion of Securities
Outcome of the meeting of the Securities Allotment Committee held today i.e. on November 08, 2022 wherein the Committee has allotted 34,50,501 equity shares of Re. 1/- each, upon conversion / exchange of equal number of warrants SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Statement On Deviation Or Variation In The Use Of Proceeds Of Preferential Issue
Statement on deviation or variation in the use of proceeds of Preferential Issue SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Board Meeting Outcome for Outcome Of The Board Meeting Held Today I.E. November 07 2022
Outcome of the Board Meeting held today i.e. November 07 2022 SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Outcome Of The Board Meeting Held Today I.E. November 07 2022
Outcome of the Board Meeting held today i.e. November 07 2022 SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Board Meeting Intimation for Unaudited Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2022
SUN PHARMA ADVANCED RESEARCH COMPANY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2022 ,inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2022 SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Announcement under Regulation 30 (LODR)-Investor Presentation
Transcript of Investor Presentation is attached SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Details of request for issue of duplicate share certificate reported by shareholder of the Company SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Details of Loss of Share Certificate SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Announcement under Regulation 30 (LODR)-Investor Presentation
Audio Playback of the Investor Presentation for Update on Clinical Programs and R&D Pipeline SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation